253
Views
123
CrossRef citations to date
0
Altmetric
Research Article

New consensus research on neuropathological aspects of familial amyotrophic lateral sclerosis with superoxide dismutase 1 (SOD1) gene mutations: Inclusions containing SOD1 in neurons and astrocytes

, , , , , , , , & show all
Pages 163-184 | Published online: 10 Jul 2009

  • Hirano A. Neuropathology of ALS: An overview. Neurology 1996; 47(Suppl 2): S63-S66.
  • de Belleroche J, Orrell RW, Virgo L Amyotrophic lateral sderosis: Recent advances in understanding disease mechanisms. J Neuropathol Exp Neurol 1996; 55: 747-757.
  • Hudson AJ. Amyotrophic lateral sclerosis and its association with dementia, Parkinsonism and other neurological disorders: A review. Brain 1981; 104: 217-247.
  • Juneja T, Pericak-Vance MA, Laing NG, Dave S, Siddique T. Prognosis in familial amyotrophic lateral sderosis: Progression and survival in patients with glu100gly and ala4val mutations in Cu,Zn Superoxide dismutase. Neurology 1997; 48: 55-57.
  • Mulder DW, Kurland LT, Offord KP, Beard CM. Familial adult motor neuron disease: Amyotrophic lateral sderosis. Neurology 1986; 36: 511-517.
  • Engel WK, Kurland LT, Klatzo L An inherited disease similar to amyotrophic lateral sderosis with a pattern of posterior column involvement An intermediate form? Brain 1959; 82: 203-220.
  • Charcot JM, Jofrroy A. Deux cas d'atrophie musculaire progressive avec lésions de la substance grise et des faisceaux antérolatéraux de la moelle épinière. Arch Physiol (Paris) 1869; 2: 744-760.
  • Siddique T, Figlewicz DA, Pericak-Vance MA, et al. Linkage of a gene causing familial amyotrophic lateral sderosis to chromosome 21 and evidence of genetic-locus heterogeneity. N Engl J Med 1991; 324: 1381-1384.
  • Deng HX, Hentati A, Tainer JA, et al. Amyotrophic lateral sderosis and structural defects in Cu, Zn Superoxide dismutase. Science 1993; 261: 1047-1051.
  • Rosen DR, Siddique T, Patterson D, et al. Mutations in Cu/Zn Superoxide dismutase gene are associated with familial amyotrophic lateral sderosis. Nature 1993; 362: 59-62.
  • Levanon D, Lieman-Hurwitz J, Dafni N, et al. Architecture and anatomy of the chromosomal locus in human chromosome 21 encoding the Cu/Zn Superoxide dismutase. EMBO J 1985; 4: 77-84.
  • Weisiger RA, Fridovich I. Mitodiondrial Superoxide dismutase: Site of synthesis and intramitodiondrial localization. J Biol Chem 1973; 248: 4793-4796.
  • Fridovich I. Superoxide dismutases. Adv Enzymol Relat Areas Mol Biol 1986; 58: 61-97.
  • Weitkamp L, Francke U. Report of the committee on the genetic constitution of chromosome 6. Cytogenet Cell Genet 1978; 22: 92-105.
  • Hendrickson DJ, Fisher JH, Jones C, Ho YS. Regional localization of human extracellular Superoxide dismutase gene to 4pter-q21. Genomics 1990; 8: 736-738.
  • Rothstein JD, Kammen MV, Levy AI, Martin U, Kund RW. Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann Neurol 1995; 38: 73-84.
  • Richardson JS, Richardson DC, Thomas KA. Similarity of three-dimensional structure between immunoglobulin domain and the copper,zinc Superoxide dismutase subunit J Mol Biol 1976; 102: 221-235.
  • Getzoff ED, Tainer JA, Stempien MM, Bell GI, Hallewell RA. Evolution of CuZn Superoxide dismutase and the Greek key beta-barrel structural motif. Proteins 1989; 5: 322-336.
  • Siddique T, Nijhawan D, Hentati A. Familial amyotrophic lateral sderosis. J Neural Transm 1997; 49(Suppl): 219-233.
  • Tainer JA, Getzoff ED, Beem KM, Richardson TS, Richardson DC. Determination and analysis of the 2 A structure of copper, zinc Superoxide dismutase. J Mol Biol 1982; 160: 181-217.
  • Bordo D, Djinovic K Bolognesi M. Conserved patterns in the Cu, Zn Superoxide dismutase family. J Mol Biol 1994; 238: 366-386.
  • Boissinot M, Karnas S, Lepock JR, et al. Function of the Creek key connection analysed using drcular permutants of Superoxide dismutase. EMBO J 1997; 16: 2171-2178.
  • Band L, Benedetto M, Bertini I, Conte RD, Picdoli M, Viezoli MS. Solution structure of reduced monomeric Q133M2 Copper, Zinc Superoxide dismutase (SOD). Why is SOD a dimeric enzyme? Biochemistry 1998; 37: 11780-11791.
  • Kato S, Saito M, Hirano A, Ohama E. Recent advances in research on neuropathological aspects of familial amyotrophic lateral sclerosis with Superoxide dismutase 1 gene mutations: Neuronal Lewy-body-like hyaline inclusions and astrocytic hyaline inclusions. Histol Histopathol 1999; 14: 973-989.
  • Nakashima K, Watanabe Y, Kuno N, Nanba E, Takahashi K Abnormality of Cu/Zn Superoxide dismutase (SOD1) activity in Japanese familial amyotrophic lateral sclerosis with two base pair deletion in the SOD1 gene. Neurology 45; 1995: 1019-1020.
  • Shibata N, Kobayashi M, Hirano A, et al. Morphological aspects of Superoxide dismutase-1 mutation in amyotrophic lateral sclerosis and its transgenic mouse model. Acta Histochem Cytochem 32; 1999: 17-30.
  • Rothstein JD, Bristol LA, Hosier B, Brown RH, Kund RW. Chronic inhibition of Superoxide dismutase produces apoptotic death of spinal neurons. Proc Natl Acad Sci USA 1994; 91: 4155-4159.
  • Troy CM, Shelanski M. Down regulation of copper/zinc Superoxide dismutase causes apoptotic death in PC 12 neuronal cells. Proc Natl Acad Sci USA 1994;91:6384-6387.
  • Phillips JP, Tainer JA, Getzoff ED, Boulianne GL, Kirby K, Hilliker AJ. Subunit-destabilising mutations in Drosophila copper/zinc Superoxide dismutase: neuropathology and a model of dimer dysequilibrium. Proc Natl Acad Sci USA 1995; 92: 8533-8534.
  • Gurney ME, Pu H, Chiu AY, et al. Motor neuron degeneration in mice that express a human Cu, Zn Superoxide dismutase mutation. Science 1994; 264: 1772-1775.
  • Andersen PM, Nilsson P, Ala-Hurula V, et al. Amyotrophic lateral sclerosis associated with homozygosity for an Asp90Ala mutation in CuZn-superoxide dismutase. Nature Genet 1995; 10: 61-65.
  • Reaume AG, Elliott JL, Hoffman EK, et al. Motor neurons in Cu/Zn Superoxide dismutase-defident mice develop normally but exhibit enhanced cell death after axonal injury. Nature Genet 1996; 13: 43-47.
  • Jackson M, Al-Chalabi A, Enayat ZE, Chioza B, Leigh PN, Morrison KE. Copper/zinc Superoxide dismutase 1 and sporadic amyotrophic lateral sclerosis: analysis of 155 cases and identification of a novel insertion mutation. Ann Neurol 1997; 42: 803-807.
  • Shaw CE, Enayat ZE, Chioza BA, et al. Mutations in all five exons of SOD-1 may cause ALS. Ann Neurol 1998; 43: 390-394.
  • Brown RH Jr. SOD1 aggregates in ALS: Cause, correlate or consequence? Nature Med 1998; 12: 1362-1364.
  • Cookson MR, Shaw PJ. Oxidative stress and motor neuron disease. Brain Pathol 1999; 9: 165-186.
  • Beckman JS, Carson M, Smith CD, Koppenol WH. ALS, SOD and peroxynitrite. Nature 1993; 364: 584.
  • Brown RH Jr. Amyotrophic lateral sclerosis - Recent insights from genetics and transgenic mice. Cell 1995; 80: 687-692.
  • Wiedau-Pazos M, Goto JJ, Rabizadeh S, et al. Altered reactivity of Superoxide dismutase in familial amyotrophic lateral sclerosis. Science 1996; 271: 515-518.
  • Singh RJ, Karoui H, Gunther MR, Beckman JS, Mason RP, Kalyanaraman B. Re-examination of the mechanism of hydroxyl radical adducts formed from the reaction between familial amyotrophic lateral sclerosis-associated Cu,Zn Superoxide dismutase mutants and H2O2. Proc Natl Acad Sei USA 1998; 95: 6675-6680.
  • Bruijn LI, Houseweart MK, Kato S, et al. Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1. Science 1998; 281: 1851-1854.
  • Bruijn LI, Beal MF, Becher MW, et al. Elevated free nitroty1osine levels but not protein-bound nitrotyrosine or hydroxyl radicals, throughout amyotrophic lateral sclerosis (ALS)-like disease implicate tyrosine nitration as an aberrant in vivo property of one familial ALS-linked Superoxide dismutase 1 mutant Proc Natl Acad Sci USA 1997; 94: 7606-7611.
  • Ferrante RJ, Shinobu LA, Schulz JB, et al. Increased 3-nitrotyrosine and oxidative damage in mice with a human copper/zinc Superoxide dismutase mutation. Ann Neurol 1997; 42: 326-334.
  • Chou SM, Wang HS, Komai K Colocalization of NOS and SOD1 in neurofilament accumulation within motor neurons of amyotrophic lateral sclerosis: an immunohisto-chemical study. J Chem Neuroanat 1996; 10: 249-258.
  • Beal MF, Ferrante RJ, Browne SE, Matthews RT, Kowall NW, Brown RH Jr. Increased 3-nitrolyrosine in both sporadic and familial amyotrophic lateral sclerosis. Ann Neurol 1997; 42: 645-654.
  • Cam MT, Battistoni A, Polizio F, Desideri A, Rotilio G. Impaired copper binding by the H46R mutant of human Cu, Zn Superoxide dismutase, involved in amyotrophic lateral sderosis. FEBS Lett 1994; 356: 314-316.
  • Nishida CR, Gralla EB, Valentine JS. Characterization of three yeast copper-zinc Superoxide dismutase mutants analogous to those coded for in familial amyotrophic lateral sderosis. Proc Natl Acad Sci 1994; 91: 9906-9910.
  • Corson LB, Strain JJ, Culotta VC, Cleveland DW. Chaperone-fadlitated copper binding is a property common to several dasses of familial amyotrophic lateral sclerosislinked Superoxide dismutase mutants. Proc Natl Acad Sci USA 1998; 95: 6361-6366.
  • Shibata N, Hirano A, Kato S, et al. Advanced grycation endproducts are deposited in neuronal hyaline inclusions: a study on familial amyotrophic lateral sclerosis with superoxide dismutase-1 mutation. Acta Neuropathol 1999; 97: 240-246.
  • Kato S, Horiuchi S, Nakashima K, et al. Astrocytic hyaline inclusions contain advanced grycation endoproducts in familial amyotrophic lateral sclerosis with Superoxide dismutase 1 gene mutation: immunohistochemical and immunoelectron microscopical analyses. Acta Neuropathol 1999; 97: 260-266.
  • Kato S, Shimoda M, Morita T, et al. Neuropathology of familial ALS with a mutation of the Superoxide dismutase 1 gene. In: Nakano I, Hirano A, editors. Amyotrophic Lateral Sclerosis: Progress and perspectives in basic research and clinical application. Amsterdam: Elsevier Science, 1996; 117-122.
  • Kato S, Shimoda M, Watanabe Y, Nakashima K, Takahashi K Ohama R Familial amyotrophic lateral sclerosis with a two base pair deletion in Superoxide dismutase 1 gene: Multisystem degeneration with intracytoplasmic hyaline inclusions in astrocytes. J Neuropathol Exp Neurol 1996; 55:1089-1101.
  • Kato S, Hayashi H, Nakashima K, et al. Pathological characterization of astrocytic hyaline inclusions in familial amyotrophic lateral sclerosis. Am J Pathol 1997; 151: 611-620.
  • Shibata N, Hirano A, Kobayashi M, Asayama K Superoxide dismutase-1 accumulation in Lewy body-like hyaline inclusions of familial amyotrophic lateral sclerosis with posterior column involvement In: Nakano I, Hirano A, editors. Amyotrophic Lateral Sclerosis: Progress and perspectives in basic research and clinical application. Amsterdam: Hsevier Science, 1996: 123-128.
  • Shibata N, Hirano A, Kobayashi M, et al. Immunohistochemical demonstration of Cu/Zn Superoxide dismutase in the spinal cord of patients with familial amyotrophic lateral sderosis. Acta Histochem Cytochem 1993; 26: 619-622.
  • Shibata N, Hirano A, Kobayashi M, et al. Intense superoxide dismutase-1 immunoreactivity in intracytoplasmic hyaline inclusions of familial amyotrophic lateral sclerosis with posterior column involvement J Neuropathol Exp Neurol 1996; 55: 481-490.
  • Bruijn LI, Becher MW, Lee MK, et al. ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions. Neuron 1997; 18: 327-338.
  • Hirano A, Kurland LT, Sayre CP. Familial amyotrophic lateral sclerosis. A subgroup characterized by posterior and spinocerebellar tract involvement and hyaline inclusions in the anterior horn cells. Arch Neurol 1967; 16: 232-243.
  • Shibata N, Hirano A, Kobayashi M, et al. Cu/Zn Superoxide dismutase-like immunoreactivity in Lewy body-like inclusions of sporadic amyotrophic lateral sclerosis. Neurosci Lett 1994; 179: 149-152.
  • Pramatarova A, Goto J, Nanba E, et al. A two basepair deletion in the SOD1 gene causes familial amyotrophic lateral sderosis. Hum Mol Genet 1994; 3: 2061-2062.
  • Metcalf CW, Hirano A. Amyotrophic lateral sderosis: Clinicopathological studies of a family. Arch Neurol 1971; 24: 518-523.
  • Dal Canto MC, Gurney MR Development of central nervous system pathology in a murine transgenic model of human amyotrophic lateral sclerosis. Am J Pathol 1994; 145: 1271-1279.
  • Dal Canto MC, Gurney MR Neuropathological changes in two lines of mice carrying a transgene for mutant human Cu,Zn SOD, and in mice overexpressing wild-type human SOD: A model of familial amyotrophic lateral sclerosis (FALS). Brain Res 1995; 676: 25-40.
  • Dal Canto MC, Gurney MR A low expressor line of transgenic mice carrying a mutant human Cu, Zn Superoxide dismutase (SOD1) gene develops pathological changes that most dosely resemble those in human amyotrophic lateral sderosis. Acta Neuropathol 1997; 93: 537-550.
  • Wong PC, Pardo CA, Borchelt DR, et al. An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron 1995; 14: 1105-1116.
  • Brännström T, Nilsson KE, Marklund S. Transgenic mice with the D9QA SOD1 mutation and motor neuron disease: a clinical, morphological, and biochemical study (abstract). Brain Pathol 1997; 7: 1073.
  • Shibata N, Hirano A, Kobayashi M, et al. Presence of Cu/Zn Superoxide dismutase (SOD) immunoreactivity in neuronal hyaline inclusions in spinal cords from mice carrying a transgene for Cly93Ala mutant human Cu/Zn SOD. Acta Neuropathol 1998; 95: 136-142.
  • Vlassara H, Bucala R, Striker L Pathogenic effects of advanced glycosylation: biochemical, biologic, and clinical implications for diabetes and aging. Lab Invest 1994; 70: 138-151.
  • Monnier VM. Toward a Maillard reaction theory of aging. In: Baynes JW, Monnier VM, editors. The Maillard Reaction in Aging, Diabetes, and Nutrition. New York Alan Liss, 1989; 1-22.
  • Ahmed MU, Thorpe SR, Baynes JW. Identification of NE-carboxymethyllysine as a degradation product of fructoselysine in glycated protein. J Biol Chem 1986; 261: 4889-4894.
  • Nagai R, Ikeda K, Higashi T, et al. Hydroxyl radical mediates NE-(carboxymethyl) lysine formation from Amadori product Biochem Biophys Res Commun 1997; 234: 167-172.
  • Aral K, Maguchi S, Fujii S, Ishibashi H, Oikawa K, Taniguchi N. Clycation and inactivation of human Cu-Zn-superoxide dismutase: Identification of the in vitro glycated sites. J Biol Chem 1987; 262: 16969-16972.
  • Ookawara T, Kawamura N, Kitagawa Y, Taniguchi N. Sitespecific and random fragmentation of Cu,Zn-superoxide dismutase by glycation reaction: Implication of reactive oxygen species. J Biol Chem 1992; 267: 18505-18510.
  • Shinohara M, Thornalley PJ, Giardino I, et al. Overexpression of glyoxalase-1 in bovine enothelial cells inhibits intracellular advanced glycation endproduct formation and prevents hyperglycemia-induced increases in macromolecular endocytosis. J Clin Invest 1998; 101: 1142-1147.
  • Giardino I, Edelstein D, Brownlee M. BCL-2 expression or antioxidants prevent hyperglycaemia-induced formation of intracellular advanced glycation endproducts in bovine endothelial cells. J Clin Invest 1996; 97:1422-1428.
  • Fuh H, Yang D, Striker L, Striker G, Vlassara H. In vivo AGE-peptide injection induces kidney enlargement and glomerular hypertrophy in rabbits: Prevention by aminoguanidine. Diabetes 1992; 41: 9A.
  • Vlassara H, Fuh H, Makita Z, Krungkrai S, Cerami A, Bucala R. Exogenous advanced glycosylation end products induce complex vascular dysfunction in normal animals: A model for diabetic and aging complications. Proc Natl Acad Sci USA 1992; 89: 12043-12047.
  • Durham HD, Roy J, Dong L, Figlewicz DA. Aggregation of mutant Cu/Zn Superoxide dismutase proteins in a culture model of ALS. J Neuropathol Exp Neurol 1997; 56: 523-530.
  • Kume S, Takeya M, Mori T, et al. Immunohistochemical and ultrastructural detection of advanced glycation end products in atherosclerotic lesions of human aorta with a novel specific monoclonal antibody. Am J Pathol 1995; 147: 654-667.
  • Kimura T, Takamatsu J, Ikeda K, Kondo A, Miyakawa T, Horiuchi S. Accumulation of advanced glycation end products of the Maillard reaction with age in human hippocampal neurons. Neurosci Lett 1996; 208: 53-56.
  • Tada J, Namikawa T, Wakayama I, Kihira T, Mizusawa H. An autopsy case of sporadic ALS with rapid clinical course and Lewy body-like intracytoplasmic inclusions in Onuf s nucleus. Neurol Med (Tokyo) 1994; 44: 377-384.
  • Kato T, Katagiri T, Hirano A, Sasaki H, Aral S. Sporadic lower motor neuron disease with Lewy body-like hyaline inclusions: a new subgroup? Acta Neuropathol 1988; 76: 208-211.
  • Matsumoto S, Kusaka H, Ito H, Shibata N, Asayama T, Imai T. Sporadic amyotrophic lateral sclerosis with dementia and Cu/Zn Superoxide dismutase-posinve Lewy body-like inclusions. Clin Neuropathol 1996; 15: 41-46.
  • Lowe J, Aldridge F, Lennox C, et al. Inclusions - bodies in motor cortex and brain-stem of patients with motor neuron disease are detected by immunocytochemical localization of ubiquitin. Neurosci Lett 1989; 105: 7-13.
  • Kihira T, Mizusawa H, Tada J, Namikawa T, Yoshida S, Yase Y. Lewy body-like inclusions in Onuf's nucleus from two cases of sporadic amyotrophic lateral sclerosis. J Neurol Sci 1993; 115: 51-57.
  • Kusaka H, Imai T, Hashimoto S, Yamamoto T, Maya K, Yamasaki M. Ultrastructural study of chromatolytic neurons in an adult-onset sporadic case of amyotrophic lateral sclerosis. Acta Neuropathol 1988; 75: 523-528.
  • Kusaka H, Matsumoto S, Imai T. Granulofilamentous profiles in lower motor neurons: a sporadic case of amyotrophic lateral sclerosis with many Lewy body-like inclusions. Clin Neuropathol 1992; 11: 20-24.
  • Kusaka H, Hirano A. Cytopathology of motor neuron. In: David SY, editor. Motor Disorders. Philadelphia: Lippincott Williams & Wilkins, 1999: 93-101.
  • Cudkowicz ME, McKenna-Yasek D, Chen C, Hedley-Whyte ET, Brown RH Jr. Limited corticospinal tract involvement in amyotrophic lateral sclerosis subjects with the A4V mutation in the Copper/Zinc Superoxide dismutase gene. Ann Neurol 1998; 43: 703-710.
  • Takahashi H. Familial amyotrophic lateral sclerosis with or without mutation of the Cu/Zn Superoxide dismutase gene. Brain Nerve 1995; 47: 535-541.
  • Saida K, Ooi N, Nabeshima K, Asada Y, Kumamoto K, Matsukura S. An autopsy case of familial amyotrophic lateral sclerosis with an His(46)Arg substitution in exon 2 of Cu/Zn-superoxide dismutase gene (Japanese abstract). 39th Annual Meeting of the Soaetas Neurologica Japonica, Kyoto, 1998.
  • Shaw CE, Enayat ZE, Powell JF, et al. Familial amyotrophic lateral sclerosis: Molecular pathology of a patient with a SOD1 mutation. Neurology 1997; 49: 1612-1616.
  • Ince PC, Shaw PJ, Slade JY, Jones C, Hudgson P. Familial amyotrophic lateral sclerosis with a mutation in exon 4 of the Cu/Zn Superoxide dismutase gene: pathological and immunocytochemical changes. Acta Neuropathol 1996; 92: 395-403.
  • Orrell RW, King AW, Hilton DA, Campbell MJ, Lane RJM, de Belleroche JS. Familial amyotrophic lateral sclerosis with a point mutation of SOD-1: intrafamilial heterogeneity of disease duration associated with neurofibrillary tangles. J Neurol Neurosurg Psychiatry 1995; 59: 266-270.
  • Rouleau GA, Clark AW, Rooke K, et al. SOD1 mutation is associated with accumulation of neurofilaments in amyotrophic lateral sclerosis. Ann Neurol 1996; 39: 128-131.
  • Kokubo Y, Kuzuhara S, Narita Y, et al. An autopsy case of familial amyotrophic lateral sclerosis with argyrophilic inclusions associated with an Ile(113)Thr substitution inexon 4 of Superoxide dismutase 1 gene. (Japanese abstract) Neuropathology 1998; 18(Suppl): 278.
  • Ince PG, Tomkins J, Slade JY, Thatcher NM, Shaw PJ. Amyotrophic lateral sclerosis associated with genetic abnormalities in the gene encoding Cu/Zn Superoxide dismutase: molecular pathology of five new cases, and comparison with previous reports and 73 sporadic cases of ALS. J Neuropathol Exp Neurol 1998; 57: 895-904.
  • Takehisa Y, Ishizu H, Ujiie H, et al. Familial amyotrophic lateral sclerosis with novel mutation Leu126Ser in copper/zinc Superoxide dismutase gene. Neuropathology 1999; 19(Suppl): 252.
  • Kadekawa J, Fujimura H, Ogawa Y, et al. A clinicopathological study of a patient with familial amyotrophic lateral sclerosis associated with a two base pair deletion in the copper/zinc Superoxide dismutase (SOD1) gene. Acta Neuropathol 1997; 94: 617-622.
  • Murayama S, Namba F4 Nishiyama K, et al. Molecular pathological studies of familial amyotrophic lateral sclerosis. Neuropathology 1997; 17(Suppl): 219.
  • Achkar CC, Bentel JM, Boylan JF, Scher HI, Cudas LJ, Miller WH Jr. Differences in the pharmacokinetic properties of orally administered all-trans-retinoic acid and 9-ds-retinoic acid in the plasma of nude mice. Drug Metabol Dis 1994; 22: 451-458.
  • Andersen PM, Nilsson P, Keranen ML, et al. Phenotypic heterogeneity in motor neuron disease patients with CuZnsuperoxide dismutase mutations in Scandinavia. Brain 1997; 120: 1723-1737.
  • Aoki M, Abe K Houi K, et al. Variance of age at onset in a Japanese family with amyotrophic lateral sclerosis associated with a novel Cu/Zn Superoxide dismutase mutation. Ann Neurol 1995; 37: 676-679.
  • Aolti M, Ogasawara M, Matsubara Y, et al. Mild ALS in Japan associated with novel SOD mutation. Nature Genet 1993; 5: 102-103.
  • Bereznai B, Winlder A, Borasio GD, GasserT. A novel SOD1 mutation in an Austrian family with amyotrophic lateral sclerosis. Neuromuscul Disord 1997; 7:113-116.
  • de Belleroche J, Orrell RW, Marklund SL Functional and structural correlates of 12 Superoxide dismutase-1 mutations in UK families with amyotrophic lateral sclerosis (abstract). 6th International Symposium on ALS/MND, Dublin, 1995.
  • Elshafey A, Lanyon WG, Connor JM. Identification of a new missense point mutation in exon 4 of the Cu/Zn superoxide dismutase (SOD-1) gene in a family with amyotrophic lateral sclerosis. Hum Mol Genet 1994; 3: 363-364.
  • Enayat ZE, Orrell RW, Claus A, et al. Two novel mutations in the gene for copper zinc Superoxide dismutase in UK families with amyotrophic lateral sclerosis. Hum Mol Genet 1995; 4: 1239-1240.
  • Esteban J, Rosen DR, Bowling AC, et al. Identification of two novel mutations and a new polymorphism in the gene for Cu/Zn Superoxide dismutase in patients with amyotrophic lateral sclerosis. Hum Mol Genet 1994; 3: 997-998.
  • Hirano M, Fujii J, Nagai Y, et al. A new variant Cu/Zn Superoxide dismutase (Val7?Glu) deduced from lymphocytes mRNA sequences from Japanese patients with familial amyotrophic lateral sclerosis. Biochem Biophys Res Commun 1994; 204: 572-577.
  • Hosier BA, Nicholson GA, Sapp PC, et al. Three novel mutations and two variants in the gene for Cu/Zn superoxide dismutase in familial amyotrophic lateral sclerosis. Neuromusc Disord 1996; 6: 361-366.
  • Ikeda M, Abe K, Ogasawara M, et al. A novel point mutation in the Cu/Zn Superoxide dismutase gene in a patient with familial amyotrophic lateral sclerosis. Hum Mol Genet 1995; 4: 491-492.
  • Jones CT, Swingler RJ, Brock DJH. Identification of a novel SOD1 mutation in an apparently sporadic amyotrophic lateral sclerosis patient and the detection of Ile113Thr in three others. Hum Mol Genet 1994; 3: 649-650.
  • Kawamata J, Hasegawa H, Shimohama S, Kimura J, Tanaka S, Ueda K Leu106?Val (CTC?GTC) mutation of superoxide dismutase-1 gene in patient with familial amyotrophic lateral sclerosis in Japan (letter). Lancet 1994; 343: 1581.
  • Kawamata J, Shimohama S, Hasegawa H, Imura T, Kimura J, Ueda K Deletion and point mutations in Superoxide dismutase-1 gene in amyotrophic lateral sclerosis (abstract). XIth TMIN International Symposium, Tokyo, 1995.
  • Kawamata J, Shimohama S, Takano S, Harada K, Ueda K, Kimura J. Novel G16S (GGC?AGC) mutation in the SOD-1 gene in a patient with apparently sporadic young-onset amyotrophic lateral sclerosis. Hum Mutat 1997; 9: 356-358.
  • Kostrzewa M, Burck-Lehmann U, Müller U. Autosomal dominant amyotrophic lateral sclerosis: a novel mutation in the Cu/Zn Superoxide dismutase-1 gene. Hum Mol Genet 1994; 3: 2261-2262.
  • Morita M, Aoki M, Abe K, et al. A novel two-base mutation in the Cu/Zn Superoxide dismutase gene associated with familial amyotrophic lateral sclerosis in Japan. Neurosci Lett 1996; 205: 79-82.
  • Moulard B, Camu W, Brice A. A previously undescribed mutation in the SOD1 gene in a French family with atypical ALS (abstract). 6th International Symposium on ALS/MND, Dublin, 1995.
  • Nakano R, Sato S, Inuzuka T, et al. A novel mutation in Cu/Zn Superoxide dismutase gene in Japanese familial amyotrophic lateral sclerosis. Biochem Biophys Res Commun 1994; 200: 695-703.
  • Orrell RW, Habgood J, Rudge P, Lane RJ, de Belleroche JS. Difficulties in distinguishing sporadic from familial amyotrophic lateral sclerosis. Ann Neurol 1996; 39: 810-812.
  • Orrell RW, Habgood J, Gardiner I, et al. Clinical and functional investigation of 10 missense mutations and a novel frameshift insertion mutation of the gene for copper-zinc Superoxide dismutase in UK families with amyotrophic lateral sclerosis. Neurology 1997; 48: 746-751.
  • Pramatarova A, Figlewicz DA, Krizus A, et al. Identifications of new mutations in the Cu/Zn Superoxide dismutase gene of patients with familial amyotrophic lateral sclerosis. Am J Hum Genet 1995; 56: 592-596.
  • Rainero I, Pinessi L, Tsuda T, et al. SOD1 missense mutation in an Italian family with ALS. Neurology 1994; 44: 347-349.
  • Sapp PC, Rosen DR, Hosler BA, et al. Identification of three novel mutations in the gene for Cu/Zn Superoxide dismutase in patients with familial amyotrophic lateral sclerosis. Neuromuscul Disord 1995; 5: 353-357.
  • Sjalander A, Beckman G, Deng H-X, Iqbal Z, Tainer JA, Sicldique T. The D90A mutation results in a polymorphism of Cu, Zn Superoxide dismutase that is prevalent in northern Sweden and Finland. Hum Mol Genet 1995; 4: 1105-1108.
  • Watanabe M, Aoki M, Abe K, et al. A novel missense mutation (S134N) of the SOD1 gene in a patient with familial motor neuron disease (abstract). XIth TMIN International Symposium, Tokyo, 1995.
  • Yulug IC, Katsanis N, de Belleroche J, Collinge J, Fisher EM. An improved protocol for the analysis of SOD1 gene mutations, and a new mutation in exon 4. Hum Mol Genet 1995; 4: 1101-1104.
  • Bonner WM, Hatch CL, Wu RS. Ubiquitinated histones and chromatin. In: Rechsteiner M, editor. Ubiquitin. New York: Plenum, 1988: 157-172.
  • Asayama K, Burr IM. Joint purification of mangano and cuprozinc Superoxide dismutases from a single source: A simplified method. Anal Biochem 1984; 136: 336-339.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.